Browsing: Daretabart

Diagnosis

FDA Grants Fast Track Designation to Daretabart for High-Risk Neuroblastoma

By NewsCancerApril 14, 20260

The FDA has granted fast track designation to daretabart (hu1418K322A) for the treatment of patients with high-risk neuroblastoma, according to…

► Necessary Cookies Always Active

Necessary cookies enable essential site features like secure log-ins and consent preference adjustments. They do not store personal data.

► Functional Cookies Remark

Functional cookies support features like content sharing on social media, collecting feedback, and enabling third-party tools.

► Analytical Cookies Remark

Analytical cookies track visitor interactions, providing insights on metrics like visitor count, bounce rate, and traffic sources.

► Advertisement Cookies Remark

Advertisement cookies deliver personalized ads based on your previous visits and analyze the effectiveness of ad campaigns.